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Abstract
Small vessel vasculitides such as microscopic polyangiitis
and Wegener’s granulomatosis commonly involve the kid-
ney and lung, with alveolar haemorrhage being the com-
monest manifestation of pulmonary involvement. Here
we describe a patient who developed acute renal failure
and pulmonary haemorrhage with positive autoantibodies
against myeloperoxidase 1 year after a diagnosis of usual
interstitial pneumonia had been made and we discuss the
uncommon association of pulmonary fibrosis and anti-
myeloperoxidase positive vasculitis.
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Introduction
Small vessel vasculitides are multisystem disorders in
which the commonest pulmonary manifestation is alveolar
haemorrhage. Pulmonary fibrosis (PF) has been less fre-
quently observed and may precede other disease features.
We describe a patient who was diagnosed with PF 1 year
prior to presentation with anti-myeloperoxidase positive
vasculitis.
Case history
A 69-year-old woman was admitted to the hospital in
February 2009 with 3 days’ history of left-sided pleuritic
chest pain, productive cough (without haemoptysis) and
dyspnoea at rest. She was a lifelong smoker but had no
previously diagnosed chest disease; her only past medical
history was of hypercholesterolaemia. She had previously
kept canaries and budgerigars but had not done so for
over 20 years, and she had no history of asbestos expo-
sure. Her regular medications consisted of aspirin and
simvastatin. On examination, she was apyrexial but hypo-
tensive (80/55 mmHg) and hypoxic with an arterial pO2
of 8.99 kPa on 28% inspired oxygen. Chest auscultation
revealed crepitations and bronchial breathing at the left
lung base, and urine dipstick showed 4+ blood and 2+
protein. Her neutrophil count was elevated at 19.7 ×
10
9/L and C-reactive protein 176 mg/L (reference range
0–10). She had a normal serum creatinine of 89 µmol/L.
Urine microscopy showed leucocytes and erythrocytes
but no casts, and culture was negative. Chest radiograph
revealed left lower lobe consolidation together with retic-
ular shadowing in the periphery of the right zone and no-
dules in the left upper zone; a previous study in October
2007 had been normal. Based on these findings, a diag-
nosis of bacterial pneumonia was made and she was com-
menced on antibiotics with good clinical response.
On review 1 month later, her cough and chest discom-
fort had resolved. However, she had ongoing exertional
dyspnoea, for example, when carrying out housework.
Chest auscultation revealed crackles in both axillae. A re-
peat chest radiograph showed resolution of her left basal
consolidation but the reticulonodular changes were still
present. Spirometry revealed a normal FEV1/FVC ratio
of 79% but reduced total lung capacity at 80% of pre-
dicted. Anti-nuclear antibodies and avian precipitins were
negative. Her urine albumin concentration was high
at >300 mg/L but with a normal serum creatinine of
92 µmol/L. In view of the clinical suspicion of pulmonary
fibrotic disease, a high-resolution chest computed tomog-
raphy scan was performed (Figure 1). This showed diffuse
fibrotic change with honeycombing in all lobes together
with subpleural ground glass shadowing and traction bron-
chiectasis in the lingula. A diagnosis of usual interstitial
pneumonia (UIP) was made. However, as her symptoms
were stable and relatively mild, it was not felt that treat-
ment was indicated.
S h er e m a i n e dw e l lu n t i lJ a n u a r y2 0 1 0w h e ns h ep r e -
sented with a 1-month history of anorexia, weight loss,
lethargy and exertional dyspnoea together with haemopty-
sis for 2 weeks. She was apyrexial and clinically euvolae-
mic with a blood pressure of 138/92 mmHg and oxygen
saturations of 98% on air. Urine dipstick showed 3+ blood
and 2+ protein. She had acute renal failure with a serum
creatinine of 630 µmol/L and haemoglobin 10.9 g/dL.
Blood and urine cultures were negative. Her perinuclear
anti-neutrophil cytoplasmic antibodies (ANCA) were
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tibody level of 403 U/L (reference range <6); anti-protein-
ase 3 and anti-glomerular basement membrane antibodies
were not detected. There was new right lower zone sha-
dowing on her chest radiograph. Percutaneous renal biopsy
showed a pauci-immune necrotizing glomerulonephritis
with crescent formation. A diagnosis of acute renal failure
and pulmonary haemorrhage secondary to microscopic
polyangiitis (MPA) was made and she was treated with
prednisolone, cyclophosphamide and plasma exchange.
She had no further haemoptysis and a repeat chest radio-
graph a few days later showed resolution of the right basal
shadowing.Herserumcreatininefelltoaround 200µmol/L.
We wondered whether her presentation with PF the previ-
ous year may have been an early manifestation of MPA,
particularly given the urinary abnormalities documented
at the time. We therefore obtained a stored serum sample
from March 2009; however, this was negative on testing
for anti-MPO antibodies.
Discussion
UIP is a term used to describe the condition previously
known as cryptogenic fibrosing alveolitis or idiopathic
PF. Patients commonly present with progressive dyspnoea
and a non-productive cough, and pulmonary function tests
show a restrictive pattern with reduced lung volumes but a
normal FEV1/FVC ratio. Plain chest radiographs usually
demonstrateinterstitialopacitiesandreducedlungvolumes,
with high-resolution computed tomography features char-
acteristically including reticulonodular opacities, honey-
comb changes and traction bronchiectasis.
MPA is a form of systemic vasculitis defined according
to the Chapel Hill classification [1] as a necrotizing vascu-
litis (with few or no immune deposits) affecting small ves-
sels such as capillaries, venules or arterioles. This
condition is usually associated with the presence of
ANCA, most commonly with a perinuclear pattern on im-
munofluorescence and specificity against MPO. Renal in-
volvement usually results in rapidly progressive renal
impairment with a pauci-immune necrotizing crescentic
glomerulonephritis on renal biopsy. Lung involvement is
also frequent, pulmonary haemorrhage being the usual
manifestation; PF is a rarely reported finding. In one Jap-
anese study of patients presenting with glomerulonephritis
in association with anti-MPO antibodies, 27 out of 40 had
evidence of non-infective interstitial pneumonitis, with co-
existing pulmonary haemorrhage in 7 [2]. However, the
occurrence of PF is much lower in most other reported se-
ries. Table 1 summarizes the cases we identified in the lit-
erature describing patients with both PF and anti-MPO
positive systemic vasculitis. Of the 58 cases where suffi-
cient data were available, PF had been diagnosed before
the development of vasculitis in 22, vasculitis preceded
the identification of PF in 1 and both conditions were iden-
tified simultaneously in 35. However, it is possible that, in
patients in whom both conditions were diagnosed at the
same time, PF may have been present beforehand but
not clinically apparent. Similarly, patients presenting ini-
tially with PF may have had evidence of vasculitis that
was not identified until later (possibly including our case).
In the 22 patients where PF was identified first, anti-
MPO antibodies were detected prior to the diagnosis of
vasculitis in 3; in the remaining 19, they were identified
when the patients presented with vasculitis but had not
been measured before this. Our patient was anti-MPO neg-
ative when the diagnosis of PF was made but became an-
tibody positive when she developed acute renal failure and
pulmonary haemorrhage secondary to MPA, perhaps sug-
gesting two unrelated pathologies. Interestingly however,
in the series reported by Foulon et al.[ 3 ] ,o n ep a t i e n t
who presented simultaneously with vasculitis and PF was
anti-MPO negative at the time, and autoantibodies were
only detected 26 months after this initial presentation. It
thus remains possible that the two conditions were indeed
Fig. 1. High-resolution computed tomography scan demonstrating
honeycomb fibrosis (H) and traction bronchiectasis (T).
Table 1. Summary of cases in the literature of PF in association with
anti-MPO positive vasculitis
Reference No. of cases
Initial presentation
(PF, pulmonary fibrosis;
V, vasculitis;
S, simultaneous)
Positive anti-MPO
preceding vasculitis
(where PF
occurred first)
[7] 2 PF, 2 Unknown
[2] 27 Unknown
[8] 3 Unknown
[9] 1 PF Unknown
[10] 1 S
[11] 4 PF, 4 Unknown
[12] 1 PF Unknown
[13] 1 PF Unknown
[14] 6 PF, 2; S, 4 Unknown
[15] 2 S
[16] 1 PF Yes
[17] 8 Unknown
[18] 19 S, 19
[19] 15 Unknown
[4] 1 PF Unknown
[20] 1 PF Unknown
[21] 1 S
[3] 5 PF, 4; S, 1 Yes, 2; unknown, 2
[22] 1 PF Unknown
[23] 12 PF, 3; V, 1; S, 8 Unknown
This case 1 PF No
352 A. Bhanji and M. Karimrelated in our case, and the presence of haematuria and
proteinuria when she presented with PF would be consis-
tent with this. To our knowledge, this is the first reported
case documenting a negative autoantibody titre at the time
of PF diagnosis.
Two main mechanisms have been proposed for the de-
velopment of PF in patients with small vessel vasculitis.
The first is that fibrosis occurs in response to pulmonary
haemorrhage which may itself be subclinical [4]. The sec-
ond is that ANCA antigens such as MPO undergo translo-
cation to the surface of neutrophils (possibly in response to
proinflammatory cytokines), and subsequent binding of
circulating ANCA results in neutrophil degranulation and
the release of reactive oxygen species, causing injury and
consequent fibrosis [5,6]. In our patient, if the PF was a
manifestation of vasculitis, this would suggest that either
the latter mechanism is not an absolute requirement for
the development of fibrosis or that autoantibody levels
too low to be detected by conventional assays may still
be sufficient to cause pathology.
In summary, PF is an uncommon but documented find-
ing in some patients with small vessel vasculitis. Whether
this is a genuine manifestation of vasculitis or a coinciden-
tal finding remains unclear; however, the fact that most
such patients have autoantibodies against MPO suggests
that there may be a true association in at least some cases.
PF may be identified at the same time as the diagnosis of
vasculitis is made or, alternatively, may precede it by
months or years. At present, there are few reports examin-
ing the presence of anti-MPO antibodies during this inter-
im period, and further study of this aspect may contribute
to the understanding of the mechanisms underlying this
possible uncommon manifestation of systemic vasculitis.
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